The Krembil Foundation's mission is to drive transformative change in healthcare and medical research through strategic investments and collaborative partnerships. Grounded in integrity and compassion, we support innovative research, empower researchers, and fund projects that strive for lasting impact.
Our Funding Interests
The Foundation has funded a wide range of medical research, but two areas continue to be funding priorities:
committed to health research
Research Grants Awarded in F’2024
One of the largest private funders in the field of neurodegeneration in Canada.
We take a long-term approach to our research; continuously looking for scientists with whom we can build lasting partnerships.
Mark Krembil
President & CEO
What We're Reading
The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into a Crisis and What We Can Do About It
Jason Karlawish
In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050.
Part case studies, part meditation on the past, present and future of the disease, The Problem of Alzheimer’s traces Alzheimer’s from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems’ failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer’s to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life.
